Your browser doesn't support javascript.
loading
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.
Gray, G Kenneth; McFarland, Braden C; Rowse, Amber L; Gibson, Sara A; Benveniste, Etty N.
Affiliation
  • Gray GK; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • McFarland BC; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Rowse AL; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Gibson SA; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Benveniste EN; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Oncotarget ; 5(15): 6484-96, 2014 Aug 15.
Article in En | MEDLINE | ID: mdl-25153725
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Casein Kinase II Limits: Female / Humans Language: En Journal: Oncotarget Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Casein Kinase II Limits: Female / Humans Language: En Journal: Oncotarget Year: 2014 Document type: Article